Clinical Response to Infliximab after Secondary Failure with Adalimumab or Certolizumab Pegol in Crohn's Disease

被引：0
|
作者：
Trivella, Juan [1 ]
Yarur, Andres [1 ]
Moroney, James [1 ]
Deshpande, Amar [1 ]
Abreu, Maria [1 ]
Sussman, Daniel [1 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01855
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1855
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [21] A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn's Disease
    Lefevre, Pavine L. C.
    Dulai, Parambir S.
    Wang, Zhongya
    Guizzetti, Leonardo
    Feagan, Brian G.
    Pop, Anca
    Yassine, Mohamed
    Shackelton, Lisa M.
    Jairath, Vipul
    Sandborn, William J.
    Vande Casteele, Niels
    BIODRUGS, 2022, 36 (01) : 85 - 93
  • [22] A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease
    Pavine L. C. Lefevre
    Parambir S. Dulai
    Zhongya Wang
    Leonardo Guizzetti
    Brian G. Feagan
    Anca Pop
    Mohamed Yassine
    Lisa M. Shackelton
    Vipul Jairath
    William J. Sandborn
    Niels Vande Casteele
    BioDrugs, 2022, 36 : 85 - 93
  • [23] Adalimumab and Certolizumab Pegol for the Treatment of Crohn's Disease: Does BMI Make a Difference?
    Moore, John M.
    Beaulieu, Dawn B.
    Horst, Sara N.
    Armstrong, Sharelle
    Duncan, Pamela A.
    Wagnon, Julianne H.
    Duley, Caroline
    Ward, Jodie
    Rosenbury, Audra
    Schwartz, David A.
    GASTROENTEROLOGY, 2011, 140 (05) : S588 - S588
  • [24] Does Obesity Impact Treatment Efficacy of Adalimumab and Certolizumab Pegol in Crohn's Disease?
    Click, Benjamin
    Tuskey, Anne G.
    Behm, Brian W.
    GASTROENTEROLOGY, 2012, 142 (05) : S361 - S361
  • [25] Crohn's disease: certolizumab, adalimumab demonstrate efficacy in prior users of infliximab
    不详
    FORMULARY, 2007, 42 (01) : 58 - 59
  • [26] Certolizumab pegol in Crohn's disease - A viewpoint
    Abreu, Maria T.
    BIODRUGS, 2007, 21 (03) : 202 - 203
  • [27] Certolizumab pegol for the treatment of Crohn's disease
    Sandborn, William J.
    Feagan, Brian G.
    Stoinov, Simeon
    Honiball, Pieter J.
    Rutgeerts, Paul
    Mason, David
    Bloomfield, Ralph
    Schreiber, Stefan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 228 - 238
  • [28] Certolizumab pegol in the treatment of Crohn's disease
    Ferrante, Marc
    Vermeire, Severine
    Rutgeerts, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (04) : 595 - 605
  • [29] Certolizumab Pegol for Active Crohn's Disease
    Blackmore, Laura J.
    Harris, Adam W.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (03) : 327 - 327
  • [30] Certolizumab pegol for the treatment of Crohn's disease
    Baker, Danial E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (06) : 683 - 691
12345